2020年7月31日,FDA公布2021财年医疗器械评审最新收费情况。 以下是FDA官方发布的2021财年FDA医疗器械评审收费表:
申请类型 | 标准收费 | 小企业收费 | 510(k) | $12,432 | $3,108 | 513g | $4,936 | $2,468 | De Novo classification | $109,697 | $27,424 | PMA, PDP, PMR, BLA | $365,657 | $91,414 | panel-track supplement | $274,243 | $68,561 | 180-day supplement | $54,849 | $13,712 | real-time supplement | $25,596 | $6,399 | BLA efficacy supplement | $365,657 | $91,414 | PMA annual report | $12,798 | $3,200 | 30-day notice | $5,851 | $2,926 | Annual Establishment Registration Fee | $5,546 |
关于卓远天成:
深圳市卓远天成咨询有限公司是一家从事医疗器械国际咨询的专业性咨询机构,可为您提供各个国家或地区医疗器械上市注册、医疗器械质量体系审查等多种国际注册及认证的咨询/代理服务。 |